CD4 and pancreatic neoplasm: Furthermore, the Th2: Th1 ratio in pancreatic tumours has been linked to patient prognosis [15], and multiple lines of evidence support a role for CD4+ T-cells in promoting pancreatic tumorigenesis [13–15, 34, 35].